PE20080550A1 - Sal xinafoato del etil ester de la 1-[[5-(1(s)-aminoetil)-2-[8-metoxi-2-(trifluorometil)-5-quinolil]-4-oxazolil]carbonil]-4(r)-[(ciclopropil-carbonil)amino]-l-prolina - Google Patents
Sal xinafoato del etil ester de la 1-[[5-(1(s)-aminoetil)-2-[8-metoxi-2-(trifluorometil)-5-quinolil]-4-oxazolil]carbonil]-4(r)-[(ciclopropil-carbonil)amino]-l-prolinaInfo
- Publication number
- PE20080550A1 PE20080550A1 PE2007000891A PE2007000891A PE20080550A1 PE 20080550 A1 PE20080550 A1 PE 20080550A1 PE 2007000891 A PE2007000891 A PE 2007000891A PE 2007000891 A PE2007000891 A PE 2007000891A PE 20080550 A1 PE20080550 A1 PE 20080550A1
- Authority
- PE
- Peru
- Prior art keywords
- carbonyl
- quinolyl
- oxazolyl
- aminoethyl
- proline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
REFERIDA A LA SAL XINAFOATO DEL ETIL ESTER DE LA 1-[[5-(1(S)-AMINOETIL)-2-[8-METOXI-2-(TRIFLUOROMETIL)-5-QUINOLIL]-4-OXAZOLIL]CARBONIL]-4(R)-[(CICLOPROPIL-CARBONIL)AMINO]-L-PROLINA. TAMBIEN ESTA REFERIDA A LAS FORMAS POLIMORFICAS DE DICHA SAL, FORMA 1, 2 Y 3 Y EL DIHIDRATO DE LA FORMA 1. LA FORMA 1 TIENE UN PATRON DE DIFRACCION DE RAYOS X DE POLVO QUE TIENE PICOS MAXIMOS DE 6,1, 7,7, 13,0 Y 15,9 GRADOS 2 THETA; LA FORMA 2 TIENE PICOS MAXIMOS DE 10,6, 13,6, 19,1 Y 21,2; EL DIHIDRATO DE FORMA 1 TIENE PICOS MAXIMOS DE 8,2, 16,5, 18,5 Y 24,9; Y LA FORMA 3 TIENE PICOS MAXIMOS DE 4,6, 7,9, 12,1 Y 18,9. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES DE LAS VIAS RESPIRATORIAS TALES COMO ASMA, BRONQUITIS, BRONQUIOLITIS, FIBROSIS PULMONAR, ENTRE OTRAS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83005706P | 2006-07-11 | 2006-07-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20080550A1 true PE20080550A1 (es) | 2008-06-13 |
Family
ID=38895717
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2007000891A PE20080550A1 (es) | 2006-07-11 | 2007-07-11 | Sal xinafoato del etil ester de la 1-[[5-(1(s)-aminoetil)-2-[8-metoxi-2-(trifluorometil)-5-quinolil]-4-oxazolil]carbonil]-4(r)-[(ciclopropil-carbonil)amino]-l-prolina |
PE2011000903A PE20110391A1 (es) | 2006-07-11 | 2007-07-11 | Polimorfos de la sal xinafoato del etil ester de la 1-[[5-(1(s)-aminoetil)-2-[8-metoxi-2-(trifluorometil)-5-quinolil]-4-oxazolil]carbonil]-4(r)-[(ciclopropil-carbonil)amino]-l-prolina |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2011000903A PE20110391A1 (es) | 2006-07-11 | 2007-07-11 | Polimorfos de la sal xinafoato del etil ester de la 1-[[5-(1(s)-aminoetil)-2-[8-metoxi-2-(trifluorometil)-5-quinolil]-4-oxazolil]carbonil]-4(r)-[(ciclopropil-carbonil)amino]-l-prolina |
Country Status (22)
Country | Link |
---|---|
US (1) | US7919505B2 (es) |
EP (1) | EP2038277A2 (es) |
JP (2) | JP5097774B2 (es) |
KR (1) | KR20090026217A (es) |
CN (1) | CN101547920B (es) |
AR (1) | AR061890A1 (es) |
AU (1) | AU2007273007B2 (es) |
BR (1) | BRPI0712915A2 (es) |
CA (1) | CA2657902A1 (es) |
CL (1) | CL2007002020A1 (es) |
CO (1) | CO6190533A2 (es) |
EC (1) | ECSP099045A (es) |
IL (1) | IL196402A0 (es) |
MX (1) | MX2009000460A (es) |
NO (1) | NO20090646L (es) |
NZ (1) | NZ574070A (es) |
PE (2) | PE20080550A1 (es) |
RU (1) | RU2009104346A (es) |
SG (1) | SG173366A1 (es) |
TW (1) | TW200813040A (es) |
WO (1) | WO2008008327A2 (es) |
ZA (1) | ZA200900208B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0511295A (pt) * | 2004-05-18 | 2007-12-04 | Schering Corp | 2-quinolil-oxazóis substituìdos úteis como inibidores de pde4 |
US7985860B2 (en) * | 2006-08-14 | 2011-07-26 | Schering Corporation | Process and intermediates for the synthesis of 2-(quinolin-5-yl)-4,5 disubstituted-azole derivatives |
WO2009009002A2 (en) * | 2007-07-10 | 2009-01-15 | Schering Corporation | Hydrogen chloride salt of a substituted 5-oxazol-2-yl-quinoline compound and a process for the production thereof |
CA2692781A1 (en) * | 2007-07-10 | 2009-01-15 | Schering Corporation | Process for the production of substituted 5-quinolyl-oxazoles and pharmaceutically acceptable salts thereof |
JP5709101B2 (ja) * | 2010-09-01 | 2015-04-30 | 東レ・ファインケミカル株式会社 | ヒドロキシプロリン誘導体の製造法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2600644B2 (ja) | 1991-08-16 | 1997-04-16 | 藤沢薬品工業株式会社 | チアゾリルベンゾフラン誘導体 |
US5352707A (en) | 1992-03-26 | 1994-10-04 | Harbor Branch Oceanographic Institution, Inc. | Method for treating airway congestion |
US5270324A (en) | 1992-04-10 | 1993-12-14 | Merck Frosst Canada, Inc. | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
US5472964A (en) | 1992-12-22 | 1995-12-05 | Merck Frosst Canada, Inc. | Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
RU2170730C2 (ru) | 1996-05-20 | 2001-07-20 | Дарвин Дискавери Лимитед | Хинолиновые карбоксамиды и фармацевтическая композиция на их основе |
JP2000510866A (ja) | 1996-05-20 | 2000-08-22 | ダーウィン・ディスカバリー・リミテッド | Tnfとpde―ivのインヒビターとしてのキノリンスルホンアミド |
US6069151A (en) | 1996-11-06 | 2000-05-30 | Darwin Discovery, Ltd. | Quinolines and their therapeutic use |
US20050017134A1 (en) | 2003-07-24 | 2005-01-27 | Hooper Patricia E. | Glass and bottle holders |
BRPI0511295A (pt) * | 2004-05-18 | 2007-12-04 | Schering Corp | 2-quinolil-oxazóis substituìdos úteis como inibidores de pde4 |
CA2603433A1 (en) * | 2005-03-30 | 2006-10-05 | Schering Corporation | Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist |
-
2007
- 2007-07-10 KR KR1020097002657A patent/KR20090026217A/ko not_active Application Discontinuation
- 2007-07-10 WO PCT/US2007/015715 patent/WO2008008327A2/en active Application Filing
- 2007-07-10 CA CA002657902A patent/CA2657902A1/en not_active Abandoned
- 2007-07-10 BR BRPI0712915-7A patent/BRPI0712915A2/pt not_active IP Right Cessation
- 2007-07-10 CN CN2007800336203A patent/CN101547920B/zh not_active Expired - Fee Related
- 2007-07-10 US US11/775,383 patent/US7919505B2/en not_active Expired - Fee Related
- 2007-07-10 MX MX2009000460A patent/MX2009000460A/es not_active Application Discontinuation
- 2007-07-10 JP JP2009519488A patent/JP5097774B2/ja not_active Expired - Fee Related
- 2007-07-10 SG SG2011050341A patent/SG173366A1/en unknown
- 2007-07-10 NZ NZ574070A patent/NZ574070A/en not_active IP Right Cessation
- 2007-07-10 AU AU2007273007A patent/AU2007273007B2/en not_active Ceased
- 2007-07-10 RU RU2009104346/04A patent/RU2009104346A/ru not_active Application Discontinuation
- 2007-07-10 EP EP07836037A patent/EP2038277A2/en not_active Withdrawn
- 2007-07-11 PE PE2007000891A patent/PE20080550A1/es not_active Application Discontinuation
- 2007-07-11 AR ARP070103086A patent/AR061890A1/es not_active Application Discontinuation
- 2007-07-11 CL CL200702020A patent/CL2007002020A1/es unknown
- 2007-07-11 PE PE2011000903A patent/PE20110391A1/es not_active Application Discontinuation
- 2007-07-11 TW TW096125280A patent/TW200813040A/zh unknown
-
2009
- 2009-01-08 IL IL196402A patent/IL196402A0/en unknown
- 2009-01-09 EC EC2009009045A patent/ECSP099045A/es unknown
- 2009-01-09 ZA ZA200900208A patent/ZA200900208B/xx unknown
- 2009-02-10 NO NO20090646A patent/NO20090646L/no not_active Application Discontinuation
- 2009-02-11 CO CO09013387A patent/CO6190533A2/es not_active Application Discontinuation
-
2012
- 2012-06-13 JP JP2012133753A patent/JP2012214482A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
KR20090026217A (ko) | 2009-03-11 |
PE20110391A1 (es) | 2011-06-22 |
JP2012214482A (ja) | 2012-11-08 |
JP2009542811A (ja) | 2009-12-03 |
CN101547920B (zh) | 2012-06-27 |
EP2038277A2 (en) | 2009-03-25 |
AU2007273007B2 (en) | 2012-11-01 |
ZA200900208B (en) | 2010-01-27 |
TW200813040A (en) | 2008-03-16 |
ECSP099045A (es) | 2009-02-27 |
BRPI0712915A2 (pt) | 2012-10-09 |
CO6190533A2 (es) | 2010-08-19 |
US7919505B2 (en) | 2011-04-05 |
MX2009000460A (es) | 2009-01-27 |
RU2009104346A (ru) | 2010-08-20 |
CN101547920A (zh) | 2009-09-30 |
NO20090646L (no) | 2009-04-07 |
CL2007002020A1 (es) | 2008-02-22 |
IL196402A0 (en) | 2009-09-22 |
NZ574070A (en) | 2011-12-22 |
AU2007273007A1 (en) | 2008-01-17 |
US20080027101A1 (en) | 2008-01-31 |
WO2008008327A2 (en) | 2008-01-17 |
SG173366A1 (en) | 2011-08-29 |
JP5097774B2 (ja) | 2012-12-12 |
WO2008008327A3 (en) | 2008-03-06 |
AR061890A1 (es) | 2008-10-01 |
CA2657902A1 (en) | 2008-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2007002099A1 (es) | Compuestos derivados de 3h-espiro(1-benzofuran-2,4'-piperidina); proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y uso para el tratamiento de enfermedades respiratorias, tales como epoc y asma. | |
CL2007003765A1 (es) | Compuestos derivados de 2-oxo-4-hidroxi-benzotiazol; procesode preparacion; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, bronquitis, asma y bronquiectasias. | |
LTC1781298I2 (lt) | Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui | |
ZA200807778B (en) | Reverse-Phase microcapsules for active ingredients, simplified process of manufacture thereof and combined formulations WDG-CS, ZC, EC-SC and CX | |
CL2007002689A1 (es) | Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras. | |
CL2007002513A1 (es) | Compuestos derivados de isoindolina sustituidos, compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento y prevencion de enfermedades tales como cancer, dolor, degeneracion macular, entre otras. | |
CL2007003635A1 (es) | Compuestos derivados de 6-amino-purin-8-ona; proceso de preparacion; composicion farmaceutica; proceso para preparar la composicion farmaceutica; y uso en el tratamiento de enfermedades alergicas, virales o cancer. | |
CL2007003690A1 (es) | Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas. | |
CL2007002610A1 (es) | Compuestos derivados de bipiridina sustituida; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento y/o la profilaxis de enfermedades tales como hipertonia, diabetes, infarto de miocardio, entre otras. | |
CL2012001464A1 (es) | Compuestos derivados de (2-amino-5,5-difluor-5,6-dihidro-4h-[1,3]oxazin-4-il)-fenilamida, inhibidores bace1 y/o bace2; composicion farmaceutica; procedimiento de preparacion; y uso en el tratamiento terapeutico y/o profilactico de enfermedades tales como alzheimer y diabetes. | |
EA201490774A1 (ru) | Новые производные оксазина и их применение при лечении заболевания | |
CL2007000161A1 (es) | Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
CL2007002274A1 (es) | Compuestos derivados del acido (3-amino-1,2,3,4-tetrahidro-9h-carbazol-9-il)-acetico; composicion farmaceutica; y uso para la prevencion y/o tratamiento de enfermedades alergicas e inmunes, tales como asma, epoc y rinitis entre otras. | |
WO2007122580A3 (en) | Compositions of phenylephrine useful for treatment of respiratory illness | |
UY30411A1 (es) | Derivados sustituidos del acetato de 2,3,4,-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones | |
CL2014002386A1 (es) | Compuesto inhibidor de cinasa de fosfoinositida 3 en forma anhidra cristalina solida; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento o prevencion de enfermedades tales como epoc, asma, entre otras. | |
WO2009149486A3 (en) | Compounds for treating beta-amyloidoses | |
EA201400392A1 (ru) | ПРОИЗВОДНЫЕ 6-ЗАМЕЩЕННЫХ ТРИАЗОЛОПИРИДАЗИНОВ КАК АГОНИСТЫ Rev-Erb | |
CL2007001481A1 (es) | Compuestos derivados de pirrolidina sustituidas, inhibidores de proteasa activadora de canal; composicion farmaceutica; y uso para el tratamiento de enfermedades tales como fibrosis quistica, bronquitis cronica, epoc, asma e infecciones de las vias r | |
WO2008154083A3 (en) | Compounds, compositions and methods for the treatment of synucleinopathies | |
WO2007093880A3 (en) | Novel pyrone-indole derivatives and process for their preparation | |
WO2008076954A3 (en) | Heterocycle compounds and methods of use thereof | |
CL2007003346A1 (es) | Compuestos derivados de 2,5-dihidro-3h-pirazolo[4,3-c]piridazin-3-ona; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como sindrome de abstinencia a una sustancia, tras | |
IL192670A (en) | Carboxylic Acids of 1, 3-Dioxane, Process for Preparation, Pharmaceutical Preparations Containing and Using it for Medication | |
MY149854A (en) | Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |